Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Muthiah Vaduganathan, M.D.

Title
Institution
Department
Address
Profile Picture

Overview
Muthiah Vaduganathan, MD MPH is a cardiologist at Brigham and Women's Hospital and Harvard Medical School (Boston, MA).

He entered the medical field as a part of Northwestern University's Honors Program in Medical Education (HPME). Through this 7-year longitudinal program, he received a bachelor's degree in biological sciences (2008) and a medical doctorate (2012). During his time at Northwestern University (Chicago, IL), he also earned a Master of Public Health degree (2012) and was inducted into the Alpha Omega Alpha Honor Medical Society. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital (Boston, MA), and served as a Chief Medical Resident at Newton-Wellesley Hospital (Newton, MA).

He is interested in drug development and clinical trials of cardiometabolic therapies. He has authored or co-authored more than 200 peer-reviewed publications. Dr. Vaduganathan serves on the editorial board of the European Journal of Heart Failure and JACC Heart Failure (Social Media / CME Editor). He serves on the ACCF/AHA Task Force on Performance Measures and is involved in an FDA Think Tank on improving future clinical trials in HF. He participates as a Clinical Endpoints Committee member for ongoing advanced-phase trials in HF / post-MI LV dysfunction and as a site investigator for DELIVER (dapagliflozin in HFpEF) and SELECT (semaglutide in obese/overweight) at Brigham and Women’s Hospital.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Vaduganathan M, Mehra MR. Reappraisal of the safety and effectiveness of Impella pumps. Nat Rev Cardiol. 2020 04; 17(4):203-204. PMID: 31937914.
    Citations:    
  2. Tahhan AS, Vaduganathan M, Greene SJ, Alrohaibani A, Raad M, Gafeer M, Mehran R, Fonarow GC, Douglas PS, Bhatt DL, Butler J. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. JAMA Cardiol. 2020 Mar 25. PMID: 32211813.
    Citations:    
  3. McCarthy CP, Chang LS, Vaduganathan M. Training the Next Generation of Cardiometabolic Specialists. J Am Coll Cardiol. 2020 Mar 17; 75(10):1233-1237. PMID: 32164896.
    Citations:    
  4. Selvaraj S, Claggett BL, Böhm M, Anker SD, Vaduganathan M, Zannad F, Pieske B, Lam CSP, Anand IS, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD. Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan. J Am Coll Cardiol. 2020 Mar 11. PMID: 32192799.
    Citations:    
  5. Ibrahim NE, Burnett JC, Butler J, Camacho A, Felker GM, Fiuzat M, O'Connor C, Solomon SD, Vaduganathan M, Zile MR, Januzzi JL. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC Heart Failure Position Paper. JACC Heart Fail. 2020 Mar 03. PMID: 32171762.
    Citations:    
  6. Chandra A, Vaduganathan M, Lewis EF, Claggett B, McMurray JJV, Solomon SD. Reply: Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2020 Mar; 8(3):245-246. PMID: 32131029.
    Citations:    
  7. Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol. 2020 Feb 26. PMID: 32101262.
    Citations:    
  8. Wadhera RK, Vaduganathan M, Jiang GY, Song Y, Xu J, Shen C, Bhatt DL, Yeh RW, Fonarow GC. Performance in Federal Value-Based Programs of Hospitals Recognized by the American Heart Association and American College of Cardiology for High-Quality Heart Failure and Acute Myocardial Infarction Care. JAMA Cardiol. 2020 Feb 19. PMID: 32074242.
    Citations:    
  9. Honigberg MC, Vardeny O, Vaduganathan M. Practical Considerations for the Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure. Circ Heart Fail. 2020 Feb; 13(2):e006623. PMID: 32059632.
    Citations:    
  10. Sumarsono A, Sumarsono N, Das SR, Vaduganathan M, Agrawal D, Pandey A. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries. JAMA Netw Open. 2020 Feb 05; 3(2):e200181. PMID: 32108893.
    Citations:    
  11. Segar MW, Vaduganathan M, McGuire DK, Basit M, Pandey A. Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306. Diabetes Care. 2020 Feb; 43(2):e26-e27. PMID: 31959648.
    Citations:    
  12. DeFilippis EM, Bajaj NS, Singh A, Malloy R, Givertz MM, Blankstein R, Bhatt DL, Vaduganathan M. Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jan 28; 75(3):320-332. PMID: 31976871.
    Citations:    
  13. McCarthy CP, Vaduganathan M, Solomon E, Sakhuja R, Piazza G, Bhatt DL, Connors JM, Patel NK. Running thin: implications of a heparin shortage. Lancet. 2020 02 15; 395(10223):534-536. PMID: 31982034.
    Citations:    
  14. Hirji SA, Percy ED, Zogg CK, Vaduganathan M, Kiehm S, Pelletier M, Kaneko T. Thirty-Day Nonindex Readmissions and Clinical Outcomes After Cardiac Surgery. Ann Thorac Surg. 2020 Jan 21. PMID: 31972128.
    Citations:    
  15. Myhre PL, Vaduganathan M, O'Meara E, Claggett BL, de Denus S, Jarolim P, Anand IS, Pitt B, Rouleau JL, Solomon SD, Pfeffer MA, Desai AS. Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study. Circ Heart Fail. 2020 Jan; 13(1):e006638. PMID: 31957468.
    Citations:    
  16. Bhatt AS, Vaduganathan M, Butler J. Growing Mismatch Between Evidence Generation and Implementation in Heart Failure. Am J Med. 2020 Jan 17. PMID: 31958429.
    Citations:    
  17. Khan MS, Memon MM, Murad MH, Vaduganathan M, Greene SJ, Hall M, Triposkiadis F, Lam CSP, Shah AM, Butler J, Shah SJ. Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2020 Mar; 22(3):472-485. PMID: 31919960.
    Citations:    
  18. Pandey A, Keshvani N, Khera R, Lu D, Vaduganathan M, Joynt Maddox KE, Das SR, Kumbhani DJ, Goyal A, Girotra S, Chan P, Fonarow GC, Matsouaka R, Wang TY, de Lemos JA. Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries. JAMA Cardiol. 2020 Jan 08. PMID: 31913411.
    Citations:    
  19. Sharma A, Vaduganathan M, Ferreira JP, Liu Y, Bakris GL, Cannon CP, White WB, Zannad F. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial. J Am Heart Assoc. 2020 Jan 07; 9(1):e012797. PMID: 31902327.
    Citations:    
  20. Desai RJ, Wang SV, Vaduganathan M, Evers T, Schneeweiss S. Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes. JAMA Netw Open. 2020 Jan 03; 3(1):e1918962. PMID: 31922560.
    Citations:    
  21. Vaduganathan M, Claggett BL, Solomon SD. How Do SGLT-2 Inhibitors Work to Prevent Heart Failure? JACC Heart Fail. 2020 Jan; 8(1):67-69. PMID: 31896418.
    Citations:    
  22. Vaduganathan M, McCarthy CP, Ayers C, Bhatt DL, Kumbhani DJ, de Lemos JA, Fonarow GC, Pandey A. Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA. Eur Heart J Qual Care Clin Outcomes. 2020 Jan 01; 6(1):62-71. PMID: 31124567.
    Citations:    
  23. Buckley LF, Vaduganathan M, Lauffenburger JC, Machado SR, Fanikos J. Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries. Ann Pharmacother. 2019 Dec 26; 1060028019897388. PMID: 31876432.
    Citations:    
  24. Myhre PL, Vaduganathan M, Greene SJ. Diagnosing heart failure with preserved ejection fraction in 2019: the search for a gold standard. Eur J Heart Fail. 2020 Mar; 22(3):422-424. PMID: 31863672.
    Citations:    
  25. Raber I, McCarthy CP, Al Rifai M, Vaduganathan M, Michos ED, Wood MJ, Smyth YM, Ibrahim NE, DeFaria Yeh D, Asnani A, Mehran R, McEvoy JW. Gender differences in industry payments among cardiologists. Am Heart J. 2019 Dec 18. PMID: 31926591.
    Citations:    
  26. Patel RB, Alenezi F, Sun JL, Alhanti B, Vaduganathan M, Oh JK, Redfield MM, Butler J, Hernandez AF, Velazquez EJ, Shah SJ. Biomarker Profile of Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial. J Card Fail. 2020 Mar; 26(3):270-275. PMID: 31857197.
    Citations:    
  27. Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL, Jessup M, Kalyani RR, Kaul S, Kosiborod M, Lindenfeld J, McGuire DK, Sabatine MS, Solomon SD, Teerlink JR, Vaduganathan M, Yancy CW, Stockbridge N, O'Connor CM. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. Circulation. 2019 Dec 17; 140(25):2108-2118. PMID: 31841369.
    Citations:    
  28. Bhatt AS, Vaduganathan M, Butler J. Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong. Eur J Heart Fail. 2020 Feb; 22(2):313-314. PMID: 31840351.
    Citations:    
  29. Vaduganathan M, Januzzi JL. Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors. Am J Cardiol. 2019 12 15; 124 Suppl 1:S20-S27. PMID: 31741436.
    Citations:    
  30. Chang LS, Vaduganathan M, Plutzky J, Aroda VR. Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration. Curr Diab Rep. 2019 Dec 04; 19(12):157. PMID: 31802265.
    Citations:    
  31. Bhatt AS, Vaduganathan M, Patel RB, Fonarow GC, Subacius HP, Konstam MA, Zannad F, Butler J, Greene SJ. Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. Eur J Heart Fail. 2020 Jan; 22(1):164-167. PMID: 31797490.
    Citations:    
  32. Vardeny O, Claggett B, Vaduganathan M, Beldhuis I, Rouleau J, O'Meara E, Anand IS, Shah SJ, Sweitzer NK, Fang JC, Desai AS, Lewis EF, Pitt B, Pfeffer MA, Solomon SD. Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure. JACC Heart Fail. 2019 Dec; 7(12):1022-1028. PMID: 31779923.
    Citations:    
  33. Mehra MR, Vaduganathan M, Fu M, Ferreira JP, Anker SD, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, Spiro TE, Deng H, Zannad F, Greenberg B. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J. 2019 Nov 21; 40(44):3593-3602. PMID: 31461239.
    Citations:    
  34. Sumarsono A, Vaduganathan M, Ajufo E, Navar AM, Fonarow GC, Das SR, Pandey A. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure. JAMA Cardiol. 2019 Nov 18. PMID: 31738371.
    Citations:    
  35. Solomon SD, Vaduganathan M, L Claggett B, Packer M, Zile M, Swedberg K, Rouleau J, A Pfeffer M, Desai A, H Lund L, Kober L, Anand I, Sweitzer N, Linssen G, Merkely B, Luis Arango J, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Circulation. 2020 Feb 04; 141(5):352-361. PMID: 31736342.
    Citations:    
  36. Khan MS, Irfan S, Khan SU, Mehra MR, Vaduganathan M. Transforming the interpretation of significance in heart failure trials. Eur J Heart Fail. 2020 Feb; 22(2):177-180. PMID: 31729133.
    Citations:    
  37. Murphy SP, McCarthy CP, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Cui J, Januzzi JL, Wasfy JH. Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. J Am Coll Cardiol. 2020 Jan 28; 75(3):344-345. PMID: 31726195.
    Citations:    
  38. Vaduganathan M, Claggett BL, Desai AS, Anker SD, Perrone SV, Janssens S, Milicic D, Arango JL, Packer M, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD. Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF. J Am Coll Cardiol. 2020 Jan 28; 75(3):245-254. PMID: 31726194.
    Citations:    
  39. Vaduganathan M, Fonarow GC, Greene SJ, DeVore AD, Albert NM, Duffy CI, Hill CL, Spertus JA, Thomas LE, Butler J. Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus. J Am Coll Cardiol. 2019 Dec 24; 74(25):3176-3178. PMID: 31727426.
    Citations:    
  40. Pandey A, Patel KV, Vongpatanasin W, Ayers C, Berry JD, Mentz RJ, Blaha MJ, McEvoy JW, Muntner P, Vaduganathan M, Correa A, Butler J, Shimbo D, Nambi V, deFilippi C, Seliger SL, Ballantyne CM, Selvin E, de Lemos JA, Joshi PH. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis. Circulation. 2019 Dec 17; 140(25):2076-2088. PMID: 31707797.
    Citations:    
  41. Vaduganathan M, Butler J. SGLT-2 inhibitors in heart failure: a new therapeutic avenue. Nat Med. 2019 11; 25(11):1653-1654. PMID: 31700170.
    Citations:    
  42. Patel RB, Al Rifai M, McEvoy JW, Vaduganathan M. Implications of Specialist Density for Diabetes Care in the United States. JAMA Cardiol. 2019 Oct 23. PMID: 31642870.
    Citations:    
  43. Greene SJ, DeVore AD, Sheng S, Fonarow GC, Butler J, Califf RM, Hernandez AF, Matsouaka RA, Samman Tahhan A, Thomas KL, Vaduganathan M, Yancy CW, Peterson ED, O'Connor CM, Mentz RJ. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. JACC Heart Fail. 2019 Nov; 7(11):980-992. PMID: 31606362.
    Citations:    
  44. Arora S, Qamar A, Gupta P, Vaduganathan M, Chauhan I, Tripathi AK, Sharma VY, Bansal A, Fatima A, Jain G, Batra V, Tyagi S, Khandelwal L, Kaul P, Rao SV, Girish MP, Bhatt DL, Gupta MD. Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study. Clin Cardiol. 2019 Dec; 42(12):1140-1146. PMID: 31593344.
    Citations:    
  45. Sumarsono A, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M. Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017. JAMA Intern Med. 2019 Sep 30. PMID: 31566649.
    Citations:    
  46. Byrne C, Pareek M, Vaduganathan M, Biering-Sørensen T, Qamar A, Pandey A, Olesen TB, Olsen MH, Bhatt DL. Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial. Eur Heart J Cardiovasc Pharmacother. 2019 Sep 14. PMID: 31529024.
    Citations:    
  47. Segar MW, Vaduganathan M, Patel KV, McGuire DK, Butler J, Fonarow GC, Basit M, Kannan V, Grodin JL, Everett B, Willett D, Berry J, Pandey A. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care. 2019 Dec; 42(12):2298-2306. PMID: 31519694.
    Citations:    
  48. Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Circulation. 2019 Oct 22; 140(17):1369-1379. PMID: 31510768.
    Citations:    
  49. Almarzooq ZI, Varshney AS, Vaduganathan M, Pareek M, Stewart GC, Estep JD, Mehra MR. Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support. JACC Cardiovasc Imaging. 2019 Sep 12. PMID: 31542528.
    Citations:    
  50. Myhre PL, Januzzi JL, Butler J, Vaduganathan M. De novo heart failure: where the journey begins. Eur J Heart Fail. 2019 Oct; 21(10):1245-1247. PMID: 31496006.
    Citations:    
  51. Khan MS, Ochani RK, Shaikh A, Vaduganathan M, Khan SU, Fatima K, Yamani N, Mandrola J, Doukky R, Krasuski RA. Assessing the Quality of Reporting of Harms in Randomized Controlled Trials Published in High Impact Cardiovascular Journals. Eur Heart J Qual Care Clin Outcomes. 2019 Sep 03. PMID: 31504381.
    Citations:    
  52. Patel RB, Nohria A, Butler J, Vaduganathan M. Dying is not what it used to be! Impact of evolving epidemiology and treatment on mode of death in heart failure. Eur J Heart Fail. 2019 Oct; 21(10):1267-1269. PMID: 31410990.
    Citations:    
  53. Machado SR, Vaduganathan M, Mehra MR. Adoption of hepatitis C virus-infected donor hearts: A "middle child" no more. J Heart Lung Transplant. 2019 Sep; 38(9):918-919. PMID: 31420158.
    Citations:    
  54. Myhre PL, Vaduganathan M, Claggett BL, Lam CSP, Desai AS, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Shah AM, Lewis EF, Rouleau J, Pitt B, Solomon SD. Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial. Eur J Heart Fail. 2019 Oct; 21(10):1288-1291. PMID: 31332920.
    Citations:    
  55. Gupta K, Prejean SP, Vaduganathan M, Golwala H, Watts TE, Aryal SR, von Mering G, Booker OJ, Ahmed MI, Bajaj NS. Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events? Int J Cardiol Heart Vasc. 2019 Sep; 24:100404. PMID: 31763435.
    Citations:    
  56. Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 Oct; 7(10):862-874. PMID: 31302043.
    Citations:    
  57. Myhre PL, Vaduganathan M, Solomon SD. Reply: Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI. J Am Coll Cardiol. 2019 Jul 09; 74(1):165-166. PMID: 31272546.
    Citations:    
  58. McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 06 25; 73(24):3230-3232. PMID: 31221266.
    Citations:    
  59. Selvaraj S, Claggett B, Shah SJ, Anand IS, Rouleau JL, Desai AS, Lewis EF, Vaduganathan M, Wang SY, Pitt B, Sweitzer NK, Pfeffer MA, Solomon SD. Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Jul; 12(7):e006125. PMID: 31220936.
    Citations:    
  60. Raber I, McCarthy CP, Vaduganathan M, Bhatt DL, Wood DA, Cleland JGF, Blumenthal RS, McEvoy JW. The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet. 2019 05 25; 393(10186):2155-2167. PMID: 31226053.
    Citations:    
  61. Arora S, Shemisa K, Vaduganathan M, Qamar A, Gupta A, Garg SK, Kumbhani DJ, Mayo H, Khalili H, Pandey A, Das SR. Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 05 21; 73(19):2454-2464. PMID: 31097167.
    Citations:    
  62. Patel KV, Li X, Kondamudi N, Vaduganathan M, Adams-Huet B, Fonarow GC, Vongpatanasin W, Pandey A. Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline. Mayo Clin Proc. 2019 05; 94(5):776-782. PMID: 31054605.
    Citations:    
  63. McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiol. 2019 May 01; 4(5):460-464. PMID: 30879022.
    Citations:    
  64. Bajaj NS, Vaduganathan M, Qamar A, Gupta K, Gupta A, Golwala H, Butler J, Goldhaber SZ, Mehra MR. Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis. PLoS Med. 2019 04; 16(4):e1002797. PMID: 31034476.
    Citations:    
  65. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019 Aug; 38(8):858-869. PMID: 31072751.
    Citations:    
  66. Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 04 16; 73(14):1827-1845. PMID: 30975301.
    Citations:    
  67. Jogu HR, Arora S, Vaduganathan M, Qamar A, Pandey A, Chevli PA, Pansuriya TH, Ahmad MI, Dutta A, Sunkara PR, Qureshi W, Vasu S, Upadhya B, Bhatt DL, Januzzi JL, Herrington D. Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry. Clin Cardiol. 2019 Jun; 42(6):592-604. PMID: 30941774.
    Citations:    
  68. McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL, de Lemos JA, Yancy C, Fonarow GC, Pandey A. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019 04 05; 2(4):e192987. PMID: 31026033.
    Citations:    
  69. Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598. PMID: 30922481.
    Citations:    
  70. Mosarla RC, Vaduganathan M, Qamar A, Moslehi J, Piazza G, Giugliano RP. Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 03 26; 73(11):1336-1349. PMID: 30898209.
    Citations:    
  71. Almarzooq Z, Pareek M, Sinnenberg L, Vaduganathan M, Mehra MR. Nine contemporary therapeutic directions in heart failure. Heart Asia. 2019; 11(1):e011150. PMID: 31031834.
    Citations:    
  72. Patel RB, Vaduganathan M, Mosarla RC, Venkateswaran RV, Bhatt DL, Bonow RO. Open Access Publishing and Subsequent Citations Among Articles in Major Cardiovascular Journals. Am J Med. 2019 09; 132(9):1103-1105. PMID: 30851265.
    Citations:    
  73. McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL, Bhatt DL. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. J Am Coll Cardiol. 2019 04 23; 73(15):2007-2009. PMID: 30846340.
    Citations:    
  74. Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, Duffy CI, Hill CL, McCague K, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Butler J. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2019 05 21; 73(19):2365-2383. PMID: 30844480.
    Citations:    
  75. McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 04 23; 73(15):2005-2007. PMID: 30846342.
    Citations:    
  76. Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 03 26; 73(11):1264-1272. PMID: 30846338.
    Citations:    
  77. Vaduganathan M, Tahhan AS, Alrohaibani A, Greene SJ, Fonarow GC, Vardeny O, Lindenfeld J, Jessup M, Fiuzat M, O'Connor CM, Butler J. Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials? JACC Heart Fail. 2019 03; 7(3):267-271. PMID: 30819383.
    Citations:    
  78. Patel RB, Vaduganathan M, Felker GM, Butler J, Redfield MM, Shah SJ. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial). Am J Cardiol. 2019 05 15; 123(10):1660-1666. PMID: 30876658.
    Citations:    
  79. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, Porterfield D, Blankstein R, Rosamond WD, Bhatt DL, Caughey MC. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation. 2019 02 19; 139(8):1047-1056. PMID: 30586725.
    Citations:    Fields:    
  80. Droppa M, Vaduganathan M, Venkateswaran RV, Singh A, Szumita PM, Roberts RJ, Qamar A, Hack L, Rath D, Gawaz M, Fuernau G, de Waha-Thiele S, Desch S, Schneider S, Ouarrak T, Jaffer FA, Zeymer U, Thiele H, Bhatt DL, Geisler T. Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial. Resuscitation. 2019 04; 137:205-212. PMID: 30790690.
    Citations:    
  81. Vaduganathan M, Machado SR, DeFilippis EM, Bajaj N, Stehlik J, Mossialos E, Jarcho JA, Mehra MR. Organ Donation and Drug Intoxication-Related Deaths in the United States. N Engl J Med. 2019 02 07; 380(6):597-599. PMID: 30726698.
    Citations:    
  82. Greene SJ, Felker GM, Giczewska A, Kalogeropoulos AP, Ambrosy AP, Chakraborty H, DeVore AD, Fudim M, McNulty SE, Mentz RJ, Vaduganathan M, Hernandez AF, Butler J. Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. Can J Cardiol. 2019 Sep; 35(9):1097-1105. PMID: 31230825.
    Citations:    
  83. Oxlund CS, Pareek M, Rasmussen BSB, Vaduganathan M, Biering-Sørensen T, Byrne C, Almarzooq Z, Olsen MH, Bhatt DL. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial. Am J Med. 2019 07; 132(7):840-846. PMID: 30721655.
    Citations:    
  84. Vardeny O, Vaduganathan M. Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for Cardiologists. JACC Heart Fail. 2019 02; 7(2):169-172. PMID: 30704605.
    Citations:    Fields:    
  85. Pareek M, Vaduganathan M, Biering-Sørensen T, Byrne C, Qamar A, Almarzooq Z, Pandey A, Olsen MH, Bhatt DL. Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Med. 2019 06; 132(6):733-739. PMID: 30659811.
    Citations:    Fields:    
  86. Byrne C, Vaduganathan M, Pareek M. Electrocardiography and left ventricular function: looking beyond hypertrophy. Hypertens Res. 2019 Apr; 42(4):580-582. PMID: 30635608.
    Citations:    Fields:    
  87. Kumar N, Simek S, Garg N, Vaduganathan M, Kaiksow F, Stein JH, Fonarow GC, Pandey A, Bhatt DL. Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency. Hypertension. 2019 01; 73(1):60-67. PMID: 30571563.
    Citations:    Fields:    
  88. Patel RB, Warraich HJ, Butler J, Vaduganathan M. Surprise, surprise: improving the referral pathway to palliative care interventions in advanced heart failure. Eur J Heart Fail. 2019 02; 21(2):235-237. PMID: 30592356.
    Citations:    Fields:    
  89. Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372. PMID: 30409566.
    Citations:    Fields:    
  90. Fudim M, Ambrosy AP, Sun JL, Anstrom KJ, Bart BA, Butler J, AbouEzzeddine O, Greene SJ, Mentz RJ, Redfield MM, Reddy YNV, Vaduganathan M, Braunwald E, Hernandez AF, Borlaug BA, Felker GM. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. J Am Heart Assoc. 2018 12 18; 7(24):e010364. PMID: 30561266.
    Citations:    Fields:    
  91. DeFilippis EM, Vaduganathan M, Machado S, Stehlik J, Mehra MR. Emerging Trends in Financing of Adult Heart Transplantation in the United States. JACC Heart Fail. 2019 01; 7(1):56-62. PMID: 30553907.
    Citations:    Fields:    
  92. Marti CN, Fonarow GC, Anker SD, Yancy C, Vaduganathan M, Greene SJ, Ahmed A, Januzzi JL, Gheorghiade M, Filippatos G, Butler J. Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges. Eur J Heart Fail. 2019 03; 21(3):286-296. PMID: 30537163.
    Citations:    Fields:    
  93. Patel RB, Vaduganathan M, Bhatt DL, Bonow RO. Characterizing High-Performing Articles by Altmetric Score in Major Cardiovascular Journals. JAMA Cardiol. 2018 12 01; 3(12):1249-1251. PMID: 30476952.
    Citations:    Fields:    
  94. Restrepo D, Vaduganathan M, Fenves AZ. Uremic Pericarditis: Distinguishing Features in a Now-Uncommon Clinical Syndrome. South Med J. 2018 12; 111(12):754-757. PMID: 30512129.
    Citations:    Fields:    
  95. Pandey A, Patel KV, Vaduganathan M, Sarma S, Haykowsky MJ, Berry JD, Lavie CJ. Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2018 12; 6(12):975-982. PMID: 30497652.
    Citations:    
  96. McCarthy CP, Vaduganathan M, Song Z. Moving Beyond the Hospital. Circulation. 2018 11 13; 138(20):2169-2171. PMID: 30571513.
    Citations:    Fields:    
  97. Greene SJ, Fonarow GC, Solomon SD, Subacius HP, Vaduganathan M, Ambrosy AP, Fudim M, Böhm M, Maggioni AP, Lewis EF, Zannad F, Butler J. Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial. Eur J Heart Fail. 2018 12; 20(12):1760-1763. PMID: 30415473.
    Citations:    Fields:    
  98. Bhagat AA, Greene SJ, Vaduganathan M, Fonarow GC, Butler J. Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization. JACC Heart Fail. 2019 01; 7(1):1-12. PMID: 30414818.
    Citations:    Fields:    
  99. Vaduganathan M, White WB, Charytan DM, Morrow DA, Liu Y, Zannad F, Cannon CP, Bakris GL. Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial). Am J Cardiol. 2019 02 01; 123(3):382-391. PMID: 30477800.
    Citations:    Fields:    
  100. Patel RB, Vaduganathan M, Rikhi A, Chakraborty H, Greene SJ, Hernandez AF, Felker GM, Redfield MM, Butler J, Shah SJ. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure. JACC Heart Fail. 2019 01; 7(1):47-55. PMID: 30409707.
    Citations:    Fields:    
  101. McCarthy CP, Vaduganathan M, McEvoy JW. Optimizing the Detection of Left Ventricular Thrombus Following Acute Myocardial Infarction in the Current Era-Reply. JAMA Cardiol. 2018 11 01; 3(11):1129. PMID: 30285031.
    Citations:    Fields:    
  102. Patel RB, Vaduganathan M. Targeting sudden death in heart failure with preserved ejection fraction: promise or pipedream? Expert Rev Cardiovasc Ther. 2018 12; 16(12):875-877. PMID: 30351178.
    Citations:    Fields:    
  103. McCarthy CP, Vaduganathan M, Pandey A. Developing evidence-based and accountable health policy in heart failure. Eur J Heart Fail. 2018 12; 20(12):1653-1656. PMID: 30295999.
    Citations:    Fields:    
  104. Arora S, Stouffer GA, Kucharska-Newton A, Vaduganathan M, Qamar A, Matsushita K, Kolte D, Reynolds HR, Bangalore S, Rosamond WD, Bhatt DL, Caughey MC. Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014. J Am Heart Assoc. 2018 10 02; 7(19):e010203. PMID: 30371336.
    Citations:    Fields:    
  105. Tahhan AS, Vaduganathan M, Greene SJ, Fonarow GC, Fiuzat M, Jessup M, Lindenfeld J, O'Connor CM, Butler J. Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review. JAMA Cardiol. 2018 10 01; 3(10):1011-1019. PMID: 30140928.
    Citations:    Fields:    
  106. Myhre PL, Vaduganathan M, Claggett BL, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Desai AS, Lewis EF, Rouleau J, Pitt B, Pfeffer MA, Solomon SD. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. JAMA Cardiol. 2018 10 01; 3(10):1000-1005. PMID: 30140899.
    Citations:    Fields:    
  107. McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, Wasfy JH, Januzzi JL. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170. PMID: 30165988.
    Citations:    Fields:    
  108. McCarthy CP, Vaduganathan M, Januzzi JL. Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment. JAMA. 2018 Aug 07; 320(5):433-434. PMID: 29889937.
    Citations:    Fields:    Translation:Humans
  109. De Feria AE, Bajaj NS, Polk DM, Desai AS, Blankstein R, Vaduganathan M. Pectus Excavatum and Right Ventricular Compression in a Young Athlete with Syncope. Am J Med. 2018 11; 131(11):e451-e453. PMID: 30076820.
    Citations:    Fields:    
  110. Vaduganathan M, Pareek M, Qamar A, Pandey A, Olsen MH, Bhatt DL. The Reply. Am J Med. 2018 09; 131(9):e389-e390. PMID: 30057182.
    Citations:    Fields:    
  111. Samman Tahhan A, Vaduganathan M, Kumar S, Okafor M, Greene SJ, Butler J. Design Elements and Enrollment Patterns of Contemporary Trials in Heart Failure With Preserved Ejection Fraction: A Systematic Review. JACC Heart Fail. 2018 08; 6(8):714-717. PMID: 30007553.
    Citations:    Fields:    
  112. Mahmood SS, Patel RB, Butler J, Vaduganathan M. Epirubicin and long-term heart failure risk in breast cancer survivors. Eur J Heart Fail. 2018 10; 20(10):1454-1456. PMID: 29972283.
    Citations:    Fields:    
  113. McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL, Bhatt DL, McEvoy JW. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 07 01; 3(7):642-649. PMID: 29800958.
    Citations:    Fields:    
  114. Njoroge JN, Cheema B, Ambrosy AP, Greene SJ, Collins SP, Vaduganathan M, Mebazaa A, Chioncel O, Butler J, Gheorghiade M. Expanded algorithm for managing patients with acute decompensated heart failure. Heart Fail Rev. 2018 07; 23(4):597-607. PMID: 29611010.
    Citations: 1     Fields:    
  115. Patel RB, Venkateswaran RV, Singh A, Bhatt DL, Fonarow GC, Passman R, Butler J, Yancy CW, Vaduganathan M. The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials: A Report of 348 Studies Registered With ClinicalTrials.gov. JACC Clin Electrophysiol. 2018 07; 4(7):944-954. PMID: 30025696.
    Citations:    
  116. Patel RB, Vaduganathan M, Greene SJ, Butler J. Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology. Eur J Heart Fail. 2018 10; 20(10):1379-1381. PMID: 29943879.
    Citations:    Fields:    
  117. Sarwar CMS, Vaduganathan M, Anker SD, Coiro S, Papadimitriou L, Saltz J, Schoenfeld ER, Clark RL, Dinh W, Kramer F, Gheorghiade M, Fonarow GC, Butler J. Mobile health applications in cardiovascular research. Int J Cardiol. 2018 Oct 15; 269:265-271. PMID: 29921516.
    Citations:    Fields:    
  118. Stern G, Rimsans J, Qamar A, Vaduganathan M, Bhatt DL. Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary care centre. EuroIntervention. 2018 06 08; 14(3):e333-e335. PMID: 29537373.
    Citations:    Fields:    
  119. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. The Reply. Am J Med. 2018 06; 131(6):e267-e268. PMID: 29784198.
    Citations:    Fields:    
  120. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. The Reply. Am J Med. 2018 06; 131(6):e263. PMID: 29784196.
    Citations:    Fields:    
  121. Vaduganathan M, Solomon SD. Expanding the global borders of heart failure: the SHOP and PEOPLE studies. Eur Heart J. 2018 05 21; 39(20):1781-1783. PMID: 29579180.
    Citations: 1     Fields:    
  122. Mehra MR, Jarcho JA, Cherikh W, Vaduganathan M, Lehman RR, Smits J, Stehlik J. The Drug-Intoxication Epidemic and Solid-Organ Transplantation. N Engl J Med. 2018 05 17; 378(20):1943-1945. PMID: 29768141.
    Citations:    Fields:    Translation:HumansPHPublic Health
  123. Qamar A, Vaduganathan M, Greenberger NJ, Giugliano RP. Oral Anticoagulation in Patients With Liver Disease. J Am Coll Cardiol. 2018 05 15; 71(19):2162-2175. PMID: 29747837.
    Citations: 1     Fields:    
  124. McCarthy CP, Vaduganathan M. Navigating Data Sharing in Cardiology From a Trainee's Perspective. J Am Coll Cardiol. 2018 05 08; 71(18):2075-2078. PMID: 29724360.
    Citations:    Fields:    
  125. Vaduganathan M, Patel RB, Mentz RJ, Subacius H, Chatterjee NA, Greene SJ, Ambrosy AP, Maggioni AP, Udelson JE, Swedberg K, Konstam MA, O'Connor CM, Butler J, Gheorghiade M, Zannad F. Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). Am J Cardiol. 2018 07 15; 122(2):255-260. PMID: 29731121.
    Citations:    Fields:    
  126. Berg DD, Vaduganathan M, Upadhyay GA, Singh JP, Mehra MR, Stewart GC. Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems. J Am Coll Cardiol. 2018 04 03; 71(13):1483-1493. PMID: 29598870.
    Citations:    Fields:    
  127. Greene SJ, Vaduganathan M, Khan MS, Bakris GL, Weir MR, Seltzer JH, Sattar N, McGuire DK, Januzzi JL, Stockbridge N, Butler J. Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes. J Am Coll Cardiol. 2018 03 27; 71(12):1379-1390. PMID: 29534825.
    Citations:    Fields:    
  128. Vijayakumar S, Vaduganathan M, Butler J. Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions. Circulation. 2018 03 06; 137(10):1060-1073. PMID: 29506996.
    Citations:    Fields:    
  129. Vaduganathan M, Claggett B, Packer M, McMurray JJV, Rouleau JL, Zile MR, Swedberg K, Solomon SD. Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure. JACC Heart Fail. 2018 07; 6(7):564-569. PMID: 29501807.
    Citations: 1     Fields:    
  130. Vaduganathan M, Claggett BL, Chatterjee NA, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Hegde SM, Desai AS, Lewis EF, Rouleau J, Pitt B, Pfeffer MA, Solomon SD. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial. JACC Heart Fail. 2018 08; 6(8):653-661. PMID: 29501806.
    Citations: 2     Fields:    
  131. Vaduganathan M, Pareek M, Qamar A, Pandey A, Olsen MH, Bhatt DL. Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT. Am J Med. 2018 08; 131(8):956-960. PMID: 29421687.
    Citations: 2     Fields:    
  132. Vaduganathan M, Harrington RA, Stone GW, Steg G, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. EuroIntervention. 2018 02 02; 13(15):e1841-e1849. PMID: 28988157.
    Citations:    Fields:    
  133. Pareek M, Vaduganathan M, Bhatt DL, Olsen MH. Reply: Intersection of fasting plasma glucose, adverse cardiac remodeling, and clinical outcomes. Int J Cardiol. 2018 02 01; 252:214-215. PMID: 29249432.
    Citations:    Fields:    Translation:Humans
  134. Samman Tahhan A, Vaduganathan M, Greene SJ, Okafor M, Kumar S, Butler J. Evolving Landscape of Clinical Trials in Heart Failure: Patient Populations, Endpoint Selection, and Regions of Enrollment. Curr Heart Fail Rep. 2018 02; 15(1):10-16. PMID: 29350324.
    Citations:    Fields:    Translation:Humans
  135. Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol. 2018 03 07; 13(3):398-405. PMID: 29339356.
    Citations: 1     Fields:    
  136. Vijayakumar S, Vaduganathan M, Butler J. Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus. Expert Rev Cardiovasc Ther. 2018 Feb; 16(2):123-131. PMID: 29298108.
    Citations:    Fields:    Translation:Humans
  137. Vaduganathan M, Samman Tahhan A, Greene SJ, Okafor M, Kumar S, Butler J. Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years. Eur J Heart Fail. 2018 06; 20(6):1068-1071. PMID: 29314445.
    Citations: 1     Fields:    
  138. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock. JACC Cardiovasc Interv. 2017 12 11; 10(23):2468-2469. PMID: 29217013.
    Citations:    Fields:    Translation:Humans
  139. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am J Med. 2018 05; 131(5):575-577. PMID: 29229471.
    Citations: 5     Fields:    
  140. Vaduganathan M, Cheema B, Cleveland E, Sankar K, Subacius H, Fonarow GC, Solomon SD, Lewis EF, Greene SJ, Maggioni AP, Böhm M, Zannad F, Butler J, Gheorghiade M. Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial. Eur J Heart Fail. 2018 04; 20(4):677-686. PMID: 29143416.
    Citations:    Fields:    Translation:Humans
  141. Vaduganathan M, Nagarur A, Qamar A, Patel RB, Navar AM, Peterson ED, Bhatt DL, Fonarow GC, Yancy CW, Butler J. Availability and Use of Shared Data From Cardiometabolic Clinical Trials. Circulation. 2018 02 27; 137(9):938-947. PMID: 29133600.
    Citations:    Fields:    
  142. Vaduganathan M, DeFilippis EM, Fonarow GC, Butler J, Mehra MR. Postmarketing Adverse Events Related to the CardioMEMS HF System. JAMA Cardiol. 2017 11 01; 2(11):1277-1279. PMID: 28975249.
    Citations: 2     Fields:    
  143. DeFilippis EM, Butler J, Vaduganathan M. Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity. Circ Heart Fail. 2017 11; 10(11). PMID: 29138249.
    Citations: 1     Fields:    
  144. Chioncel O, Collins SP, Greene SJ, Pang PS, Ambrosy AP, Antohi EL, Vaduganathan M, Butler J, Gheorghiade M. Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure. Card Fail Rev. 2017 Nov; 3(2):122-129. PMID: 29387465.
    Citations: 1     
  145. Greene SJ, Butler J, Fonarow GC, Subacius HP, Ambrosy AP, Vaduganathan M, Triggiani M, Solomon SD, Lewis EF, Maggioni AP, Böhm M, Chioncel O, Nodari S, Senni M, Zannad F, Gheorghiade M. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail. 2018 02; 20(2):281-291. PMID: 29044915.
    Citations: 2     Fields:    Translation:Humans
  146. Butler J, Vaduganathan M. Glucose-Lowering Therapies in Patients With Concomitant Diabetes Mellitus and Heart Failure: Finding the "Sweet Spot". JACC Heart Fail. 2018 01; 6(1):27-29. PMID: 29032135.
    Citations:    Fields:    
  147. Vaduganathan M, Qamar A, Aragam K. Preparing Fellows for Precision Cardiology: Are We Ready? J Am Coll Cardiol. 2017 09 26; 70(13):1675-1679. PMID: 28935042.
    Citations:    Fields:    
  148. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience. JACC Cardiovasc Interv. 2017 08 28; 10(16):1712-1714. PMID: 28838482.
    Citations: 1     Fields:    
  149. Sarwar CMS, Vaduganathan M, Butler J. Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials. Curr Heart Fail Rep. 2017 08; 14(4):203-209. PMID: 28647916.
    Citations:    Fields:    Translation:Humans
  150. Patel RB, Shah SJ, Fonarow GC, Butler J, Vaduganathan M. Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT. Curr Heart Fail Rep. 2017 08; 14(4):217-222. PMID: 28647918.
    Citations: 1     Fields:    Translation:Humans
  151. Khan MS, Fonarow GC, Ahmed A, Greene SJ, Vaduganathan M, Khan H, Marti C, Gheorghiade M, Butler J. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. Circ Heart Fail. 2017 Aug; 10(8). PMID: 28790052.
    Citations: 1     Fields:    Translation:Humans
  152. Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX). Am J Cardiol. 2017 Oct 01; 120(7):1043-1048. PMID: 28802512.
    Citations:    Fields:    Translation:Humans
  153. Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event. Eur J Prev Cardiol. 2017 10; 24(15):1648-1659. PMID: 28644092.
    Citations: 2     Fields:    Translation:Humans
  154. Vaduganathan M, Patel NK, Bergmark BA. Collaborative Care in an Evolving Health Care Delivery Landscape: Cardiology Fellows in Training and Advanced Practice Professionals. JAMA Cardiol. 2017 06 01; 2(6):587-588. PMID: 28467529.
    Citations:    Fields:    
  155. Knelson EH, Vaidya A, Rawizza HE, Vaduganathan M, O'Gara PT. On the Cusp. N Engl J Med. 2017 05 25; 376(21):e45. PMID: 28538122.
    Citations:    Fields:    Translation:HumansCells
  156. Vaduganathan M, Patel RB, Butler J, Metra M. Integrating electronic health records into the study of heart failure: promises and pitfalls. Eur J Heart Fail. 2017 09; 19(9):1128-1130. PMID: 28544192.
    Citations: 2     Fields:    
  157. Badreldin HA, Carter D, Cook BM, Qamar A, Vaduganathan M, Bhatt DL. Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention. Am J Cardiol. 2017 Aug 01; 120(3):359-361. PMID: 28576266.
    Citations:    Fields:    Translation:Humans
  158. Greene SJ, Vaduganathan M, Gheorghiade M. Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 07; 19(7):870-872. PMID: 28464398.
    Citations:    Fields:    Translation:Humans
  159. Berg DD, Vaduganathan M, Nohria A, Davids MS, Alyea EP, Torre M, Padera RF. Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia. Eur J Heart Fail. 2017 05; 19(5):682-685. PMID: 28485549.
    Citations: 2     Fields:    Translation:HumansCells
  160. D'Elia E, Iacovoni A, Vaduganathan M, Lorini FL, Perlini S, Senni M. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. Eur J Heart Fail. 2017 06; 19(6):710-717. PMID: 28326642.
    Citations: 2     Fields:    Translation:Humans
  161. Vaduganathan M, Bhatt DL. Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk. Am J Nephrol. 2017; 45(4):301-303. PMID: 28376487.
    Citations: 1     Fields:    
  162. Pareek M, Vaduganathan M, Bhatt DL, Leósdóttir M, Olsen MH. Prognostic implications of fasting plasma glucose in subjects with echocardiographic abnormalities. Int J Cardiol. 2017 Aug 15; 241:423-429. PMID: 28314485.
    Citations:    Fields:    Translation:HumansPHPublic Health
  163. Vaduganathan M, Patel RB, Michel A, Shah SJ, Senni M, Gheorghiade M, Butler J. Mode of Death in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2017 Feb 07; 69(5):556-569. PMID: 28153111.
    Citations: 9     Fields:    Translation:Humans
  164. Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials. JAMA Cardiol. 2017 02 01; 2(2):127-135. PMID: 27902833.
    Citations: 2     Fields:    
  165. Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Jan 17; 69(2):176-185. PMID: 28081827.
    Citations:    Fields:    Translation:Humans
  166. Vaduganathan M, Bhatt DL. Gastrointestinal Bleeding With Oral Anticoagulation: Understanding the Scope of the Problem. Clin Gastroenterol Hepatol. 2017 05; 15(5):691-693. PMID: 28089849.
    Citations: 1     Fields:    Translation:Humans
  167. Vaduganathan M, Samman-Tahhan A, Patel RB, Kelkar A, Papadimitriou L, Georgiopoulou VV, Greene SJ, Kalogeropoulos AP, Peterson E, Fonarow GC, Gheorghiade M, Butler J. Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review. Int J Cardiol. 2017 Mar 01; 230:301-303. PMID: 28041703.
    Citations: 1     Fields:    Translation:Humans
  168. Vaduganathan M, Patel NK, Lubitz SA, Neilan TG, Dudzinski DM. A "Malignant" Arrhythmia: Cardiac Metastasis and Ventricular Tachycardia. Tex Heart Inst J. 2016 Dec; 43(6):558-559. PMID: 28100983.
    Citations:    Fields:    Translation:Humans
  169. Vaduganathan M, Qamar A, Singh A, Venkateswaran RV, Szumita PM, Croce KJ, Mauri L, Leopold JA, Shah PB, Sobieszczyk P, Faxon DP, Bhatt DL. Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol. 2017 01 31; 69(4):463-464. PMID: 27914699.
    Citations:    Fields: